Phase1, Single Dose, Crossover Study to Determine Bioequivalence

A Phase 1, Open-Label, Randomized, Single-Dose, 2-Way Crossover Study To Determine Bioequivalence Of 4 Mg Fesoterodine SR Tablet Between Formulation D And Formulation E(1) In Healthy Subjects.

The objective of this study is to demonstrate bioequivalence of 4 mg tablet of formulation D and formulation E(1).

Inclusion Criteria:

• Healthy male or female Chinese or Japanese subjects

Exclusion Criteria:

• Evidence or history of clinically significant findings at screening